Trial Profile
A phase I trial to evaluate a neuroblastoma vaccine
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 06 Jun 2014
Price :
$35
*
At a glance
- Drugs Neuroblastoma vaccine (Primary)
- Indications Neuroblastoma
- Focus Adverse reactions
- 06 Jun 2014 New trial record
- 12 May 2014 According to a MabVax media release, the early results from this trial will be used to prepare for a phase II clinical trial in 2015.